A phase-I randomized euglycemic clamp study to demonstrate the pharmacokinetic and pharmacodynamic equivalence of an insulin degludec biosimilar (B01411) with the reference product in healthy Chinese volunteers-Reference-Cited by-同舟云学术

A phase-I randomized euglycemic clamp study to demonstrate the pharmacokinetic and pharmacodynamic equivalence of an insulin degludec biosimilar (B01411) with the reference product in healthy Chinese volunteers

Published:2023-08-03 Issue:8 Volume:32 Page:773-781
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Liu Hui¹,Li Ting²,Yu Hongling³,Chen Xinlei³,Li Jiaqi³,Tan Huiwen³,Jia Dejia⁴,Yu Yerong³^ORCID

Affiliation:

1. General Practice Ward/International Medical Center Ward, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, China

2. Health Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, China

3. Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China

4. Department of Research and Development, Jilin Huisheng Biopharmaceutical Co. Ltd, Jilin, China

Funder

Jilin Huisheng Biopharmaceutical Co., Ltd

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2023.2254690

Reference49 articles.

1. Basal and 24-h C-peptide and insulin secretion rate in normal man

2. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.

3. Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes

4. Basal insulin for the management of diabetic ketoacidosis;Barski L;Eur J Internal Med,2018

5. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of insulin degludec biosimilar B01411 versus originator insulin degludec in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs: a multicenter, randomized, open-label, phase 3 study;Current Medical Research and Opinion;2024-09-05